Dimitri Daldegan-Bueno

Ms. Dimitri Daldegan-Bueno

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in Substance Abuse Treatment, Prevention, and Policy
Verified
Journal Article
Open access
PDF file
BFBenedikt Fischer
Benedikt Fischer
COCaroline O’kEefe-Markman
Caroline O’kEefe-Markman
ALAngelica (Min-Hye) Lee
Angelica (Min-Hye) Lee
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
In the early 2000s, increasing prevalence of psycho-stimulant (e.g., crack/cocaine, methamphetamine) use and related harms, including severe adverse health outcomes, was observed among - mostly marginalized - populations of persons using illicit drugs in North America, underscoring an urgent need for interventions options towards improved prevention and treatment. By about 2010, however, the ‘opioid crisis’, featuring unprecedented use and public health burden, had accelerated into full force in North America, largely muting attention to the psycho-stimulant issue until recently. Recent surveillance data on drug use and related mortality/morbidity from the present decade has documented a marked resurgence of psycho-stimulant use and harms especially in at-risk populations, commonly in direct combination with opioids, across North America, resulting in a ‘twin epidemic’ comprised of opioids and psycho-stimulants We briefly review select epidemiological data indicators for these developments from the United States and Canada; in the latter jurisdiction, related evidence has been less prevalent and systematic but corroborating the same trends. Evidently, the (widely ongoing) focus on the ‘opioid epidemic’ as a ‘mono-type’ drug problem has become an anachronism that requires urgent and appropriate correction. We then briefly consider existing, evidence-based options for – prevention and treatment – interventions targeting psycho-stimulant use and harms, which are substantially more limited and/or less efficacious than those available for problematic opioid use, while presenting major gaps and challenges. The observed resurgence of psycho-stimulants may, indirectly, relate to recent efforts towards curtailing (medical) opioid availability, thereby accelerating demand and supply for both illicit opioids and psycho-stimulants. The presently unfolding ‘twin epidemic’ of opioids and psycho-stimulants, combined with limited intervention resources, presents an acute challenge for public health and may crucially undermine actively extensive efforts to reduce opioid-related health harms in North America.

8 November 2022 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
LMLucas Oliveira Maia
Lucas Oliveira Maia
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
IWIsabel Wießner
Isabel Wießner
DADraulio B. Araujo
Draulio B. Araujo
LTLuís Fernando Tófoli
Luís Fernando Tófoli

1 February 2022 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
IWIsabel Wießner
Isabel Wießner
MFMarcelo Falchi
Marcelo Falchi
LMLucas Oliveira Maia
Lucas Oliveira Maia
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
FPFernanda Palhano-Fontes
Fernanda Palhano-Fontes
LTLuís Fernando Tófoli
Luís Fernando Tófoli
Background: Controversy surrounds psychedelics and their potential to boost creativity. To date, psychedelic studies lack a uniform conceptualization of creativity and methodologically rigorous designs. Aims: This study aimed at addressing previous issues by examining the effects of lysergic acid diethylamide (LSD) on creativity using multimodal tasks and multidimensional approaches. Methods: In a randomized, double-blind, placebo-controlled, crossover study, 24 healthy volunteers received 50 μg of LSD or inactive placebo. Near drug peak, a creativity task battery was applied, including pattern meaning task (PMT), alternate uses task (AUT), picture concept task (PCT), creative metaphors task (MET) and figural creativity task (FIG). Creativity was assessed by scoring creativity criteria (novelty, utility, surprise), calculating divergent thinking (fluency, originality, flexibility, elaboration) and convergent thinking, computing semantic distances (semantic spread, semantic steps) and searching for data-driven special features. Results: LSD, compared to placebo, changed several creativity measurements pointing to three overall LSD-induced phenomena: (1) ‘pattern break’, reflected by increased novelty, surprise, originality and semantic distances; (2) decreased ‘organization’, reflected by decreased utility, convergent thinking and, marginally, elaboration; and (3) ‘meaning’, reflected by increased symbolic thinking and ambiguity in the data-driven results. Conclusion: LSD changed creativity across modalities and measurement approaches. Three phenomena of pattern break, disorganization and meaning seemed to fundamentally influence creative cognition and behaviour pointing to a shift of cognitive resources ‘away from normal’ and ‘towards the new’. LSD-induced symbolic thinking might provide a tool to support treatment efficiency in psychedelic-assisted therapy.

26 May 2022 in Journal of Psychoactive Drugs
Verified
Journal Article
Closed access
APAlexandre Augusto de Deus Pontual
Alexandre Augusto de Deus Pontual
HSH. G. Senhorini
H. G. Senhorini
CCC. M. Corradi-Webster
C. M. Corradi-Webster
LTL. F. Tófoli
L. F. Tófoli
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
There has been a revival of research that studies the subjective effects of psychedelic drugs on humans. Areas of health science have been studying their possible therapeutic benefits, and psychological measurement instruments are being developed as the studies progress. However, these instruments currently suffer criticism regarding their number and evidence of psychometric quality. This study aims to review which psychometric instruments are available to assess subjective states induced by psychedelics. We systematically searched five databases (Web of Science, Academic Search Premier, EMBASE, CINAHL and PubMed) using psychometrics and psychedelics related terms identifying studies published from 1990 to 2021. Of 857 articles generated from the systematic-search, fifteen met our criteria and were included in the review, evaluating nine instruments: MEQ, 5D-ASC, HRS, PSI, EDI, CEQ, EBI, EDI and PIQ. Eight dealing with phenomenological aspects of the psychedelic experience and one as a screening tool for psychotic or manic episode. The purpose of each instrument, the number of items in each version, the type of scale and their elaboration process were described. The number of instruments used in psychedelic research is growing steadily, but there are still many other parts of the psychedelic experience that lack measurement.

7 December 2020 in Journal of Psychoactive Drugs
Verified
Journal Article
Closed access
LMLucas Oliveira Maia
Lucas Oliveira Maia
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
LTLuís Fernando Tófoli
Luís Fernando Tófoli
Diseases that threaten life raise existential questions that can be a source of psychological distress. Studies with psychedelics demonstrate therapeutic effects for anxiety and depression associated with life-threatening illnesses. Ayahuasca has been proposed as a possible therapeutic agent in the treatment of psychiatric disorders. Preliminary studies suggest that ayahuasca could promote therapeutic effects for people with physical illnesses. The aim of this study was to explore how the ritual use of ayahuasca during the treatment of severe physical illnesses (SPI) may influence the way people understand and relate to their illness, using qualitative methods to assess the participants’ perspectives. Participants who consumed ayahuasca ritualistically during the period of treatment for SPI were purposely chosen. Data were obtained through semi-structured interviews. A thematic analysis was performed with 14 individuals. The ritual experience with ayahuasca acted on the participants’ illness understanding through multiple psychological mechanisms, including introspection, self-analysis, emotional processing and catharsis, recall of autobiographical memories subjectively related to illness origin, illness resignification, and perspective changes. This study suggests that the experience with ayahuasca may facilitate illness acceptance through an influence on the meanings of the illness, life, and death. These changes may favor a more balanced relationship with illness and treatment.

18 February 2022 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
DDDimitri Daldegan-Bueno
Dimitri Daldegan-Bueno
LMLucas Oliveira Maia
Lucas Oliveira Maia
CMCarolina Marcolino Massarentti
Carolina Marcolino Massarentti
LTLuís Fernando Tófoli
Luís Fernando Tófoli